The efficiency of translation depends on correct tRNA-ribosome interactions. 
Base pairing of the tRNA anticodon with the mRNA codon is an integral part of tRNA's functioning as an "adapter" between the genetic information stored in nucleic acids and the amino acid sequences of proteins (1) . However, when free in solution, tRNAs bind to their trinucleotide codons only weakly; any related but erroneous triplets are recognized 10-1 to 10-2 times as efficiently as the correct triplets (2) . Therefore, hydrogen bonding of tRNA anticodons to their trinucleotide codon is not sufficiently accurate to account for the genetic code's being read with an error frequency of 5 x 10-3 to 1 x 10-5, including the proofreading step (3) . General properties of RNA structure, such as the overall conformation of the anticodon domain, and particular contributions of the 2'-OH of the ribose, modified nucleosides (4, 5) , and ion coordination (6-8) must contribute to the effectiveness of ribosome-mediated codon binding.
The anticodon domain of tRNA appears to be exclusively in contact with the Escherichia coli ribosome's 30S subunit (9) . An oligomer comprising the tRNAPhe anticodon domain only, tRNA~h, binds to the poly(U)-programmed 30S ribosomal subunit with the stoichiometry and binding constant identical to those of deacylated native tRNAPhe. In addition, the anticodon domain and tRNAPhe compete for the same binding site on the ribosome (10) . These data indicate that the interaction of tRNAPhe with poly(U)-programmed 30S subunits is primarily a result of contacts in the anticodon domain and not with other parts of the tRNA.
Unmodified yeast tRNA Pl binds poly(U)-programmed small ribosomal subunits with an affinity two orders of magnitude lower than the fully modified native tRNAC (11) .
Transfer RNAs contain more than 80 differently modified nucleosides, and the nucleosides of eukaryotic tRNAs are as much as 25% modified (4, 5) . The introduction of these bases into tRNA is a post-transcriptional event involving specific enzymes. Although the functions of modified nucleosides in tRNA molecules are not yet well understood, several studies show that tRNA structure (12) , metal ion binding (6) (7) (8) , and interaction with cognate aminoacyl-tRNA synthetase are substantially influenced by the presence of modified nucleosides (13) (14) (15) (16) . By directing the local or global structural changes in tRNA, these base modifications can affect the tRNA's interaction with different macromolecules (5). Structural analogs ofthe yeast tRNAPhe anticodon domain in which either the entire sequence or just the stem were composed of unmodified deoxyribonucleosides did not bind to poly(U)-programmed 30S ribosomal subunits (11) . Therefore, questions remain as to whether modified nucleosides are important in ribosome-mediated codon binding and whether DNA analogs might be altered to bind the ribosome at the same site as tRNA. We have found that a m5C-dependent Mg2+-stabilized yeast tRNAPhe anticodon domain and a m'G-aided open loop conformation are important conformational determinants of a strong yeast tRNAPhn-ribosome interaction. When these structural elements were incorporated into a DNA analogs of the anticodon domain, the analogs effectively inhibited tRNA'hc-nribosome interaction.
MATERIALS AND METHODS Materials. Brewer's yeast tRNAPhe, poly(A), and poly(U) were purchased from Sigma. Concentrations of native brewer's yeast tRNAPhe were calculated on the basis of 1307 pmol/A260 unit. [-y-32P]ATP was purchased from New England Nuclear. Five RNAs with sequences corresponding to the yeast tRNAPhe anticodon stem and loop ( Fig. 1 Upper Left), but differing in modified nucleosides, were produced by automated chemical synthesis (17) . Modified nucleoside phosphoramidites were synthesized from the corresponding modified nucleosides (A.M., B.N., E.S., A.K., and J.J., unpublished work). They were deprotected and purified as previously described (8) . The anticodon domain were synthesized and purified as described (7, 8) .
sequences corresponding to that of the anticodon stem and loop domain of yeast tRNAPhe were synthesized and purified as described before (7 Ribosomes, from which 30S subunits were prepared, were isolated from the RNase-deficient E. coli strain MRE600 (18, 19) . The A2o/Ao ratio of the 30S ribosomal subunit preparations was between 1.8 and 1.9. Ribosomal subunit concentrations were calculated from the absorbance measurements on the basis of 70 pmol/A260 unit (19) .
Phosphorylation of the Yeast tRNAPw and tRNAe and DNA Anlog. The tRNAPhe anticodon stem/loop domains and their DNA analogs were 5'-end-labeled with 32P by using ['y32P]ATP and T4 polynucleotide kinase (20) .
Ribosome Binding of tRNA,, and tDNA b. The interactions of tRNAPhl and tDNAA4'c analogs with poly(U) or poly(A)-programmed 30S ribosomal subunits were assayed by using a nitrocellulose filtration method (10 subunits was higher. The data are presented with these negative controls already subtracted.
There are two tRNA-binding sites on the 30S subunits (21) . location to that of native tRNA, the assay was altered to measure the ability of each unlabeled tRNAPhe domain to compete with 5'-32P-labeled native tRNAPhe for programmed 30S ribosomal subunits. In the presence of increasing amounts of the tRNA~Ph domains, less native tRNAPhe was bound to the 30S subunits (Fig. 3) . However, the abilities of the variously modified tRNA1 domains to compete with tRNAPhe for the 30S subunits were quite different. When equal in concentration to tRNAPhe, both tRNAPhl-(m'G11, m5C14) and tRNAPhe-(m1G11) were able to inhibit more than 50% of the tRNAPhe from binding the 30S subunit (Fig. 3) and an open 7-membered loop (6) (7) (8) . However, tRNAAhC-(mlG'1, m5C14), the best competitor of tRNAPhe in the ribosome binding assay (Fig. 3 (6, 8) . In addition, A is substituted for T7 to disrupt the ThA10 base pair in tDNAhC*-d(A7, Ul3m5Cl4UU5) (Fig. 1) . In tDNA~c-d(G6P, U13m5C14U'5), G substitutes for C6 to disrupt the C6 G11 base pair and dU substitutes for T7. U7 corresponds to the invariant U33 that is important for a sharp "U-turn" in the anticodon loop and for maintenance of both 3' and 5' base stacking in the domain (27) . Uridine is present at position 33 in 97% of all sequences of prokaryotic, eukaryotic, mitochondrial, and archaebacterial tRNAs (28) . A structural rationale for this constancy comes from an examination of the crystal structure of yeast tRNAPhe, which suggests that U33 forms two hydrogen bonds to stabilize the sharp turn that occurs in the anticodon loop after position 33 (29) . The tDNAXhe-d(U7, m'G11, U13m5C14U15) sequence most closely resembles that of the tRNA anticodon domain in its modification, and the methylation ofG'1 should effectively inhibit the formation ofthe C6-G'1 (Fig. 4) . Therefore, tDNAT d(G6U7, Ul3m5Cl4UU5) was comparable to unmodified tRNA;
and considerably better than tRNAhce-(m5C14) and tRNA>-d(m5C14) (Fig. 3) , as wellas the other DNA analogs, in inhibiting tRNAPhe from binding poly(U)-programmed 30S subunits.
The analog tRNAhC'e-d(G6U7, U13m5C14U15) was a better inhibitor to native tRNAPhe binding 30S subunits than tDNAcA-d(A7, U13m5C'4U15). We expected that tDNAAc- Binding of tDNAAc to the Poly(U)-rgrammed 308 RibosoMl Subunit. Unmodified tDNAPh does not bind the poly(U)-programmed 30S ribosomal subunit (11) . We have designed DNA analogs with modified nucleosides to have the structural (7) and functional properties important to tR-NAZI, and these tDNAPAhc analogs successfully inhibited native tRNAPhe binding to 30S ribosomal subunits (Fig. 4) . (Fig. 2) , tDNAAnCe-(U13m5C14U15) did not bind to poly(U)-programmed 30S subunits (Fig. 5) . Although correct anticodon-codon interaction is essential to translational fidelity, the three bases of the anticodon of tRNA are not the only nucleotides of the anticodon domain that are important in the tRNA's interaction with the ribosome and mRNA. The performance of a tRNA in translation is determined by an "extended anticodon" (31) . We postulated that m5C40 of native yeast tRNAPhe is important in producing a Mg2+-regulated dynamic of the anticodon loop structure in which alternative conformations are recognized for different tRNA functions (6) . We also postulated that modified.nucleosides of the anticodon loop aid in this dynamic. For instance, the hypermodified base Y at position 37, 3'-adjacent to the anticodon, is a G modified in such a way as to prevent H-bonding to N1 and the C2 amino group. The tricylic Y's inability to base pair facilitates the open-loop conformation (6) ; its increased hydrophobic character, as compared with G. is important to an improved base stacking ofthe anticodon (32) . Since there are two tRNA-binding sites on 30S ribosomal subunits (21) , the affinity of tRNAPhle to the two sites on the ribosome are probably differentially affected by modification and ion binding. To determine if anticodon loop modifications were important to the ribosome binding of other tRNAs, we screened the 507 reported tRNA sequences (European Molecular Biology Laboratory, tRNA sequence data bank, Heidelberg) for their potential to form WatsonCrick base pairs across the anticodon loop. Of the 121 sequences with the potential of forming two canonical base pairs across the anticodon loop, one of which involves an anticodon base, 115, or 95%, were modified in a way as to preclude one base pair (Table 1 ). All of the remaining six sequences had the potential of forming two A-U base pairs.
The inability of unmodified tDNAAc to bind to poly(U)-programmed 30S ribosomal subunits (11) or to compete with native tRNAPhe for 30S ribosomal subunits is due to the absence ofmodified nucleoside structural constraints, as well as absence ofthe 2'-OHs. The tDNA analogs, tNAP-d(A7, U13m5C14U15), tDNA2-d(U7, m1G"1, Ul3mSCl4UL5), and tDNAPht-d(G6U7, U%3m5CM4U15), were effective inhibitors of 
